Novosom Smarticles® to Encapsulate Isis Antisense Drugs
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)
Published: 26 Aug-2008
DOI: 10.3833/pdr.v2008.i99.142 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Novosom has licensed antisense drugs from Isis to which it will apply its Smarticle® technology for effective delivery...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS